Report cover image

Progestrone Market by Type (Natural Progesterone, Synthetic Progesterone), Mode of Delivery (Injectable, Oral, Suspended Form), Application - Global Forecast 2023-2030

Publisher 360iResearch
Published Oct 04, 2023
Length 194 Pages
SKU # IRE18321863

Description

Progestrone Market by Type (Natural Progesterone, Synthetic Progesterone), Mode of Delivery (Injectable, Oral, Suspended Form), Application - Global Forecast 2023-2030


The Progestrone Market size was estimated at USD 1.15 billion in 2022 and expected to reach USD 1.30 billion in 2023, at a CAGR 13.32% to reach USD 3.14 billion by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Progestrone Market.
  • Based on Type, market is studied across Natural Progesterone and Synthetic Progesterone. The Natural Progesterone is projected to witness significant market share during forecast period.
  • Based on Mode of Delivery, market is studied across Injectable, Oral, and Suspended Form. The Injectable is projected to witness significant market share during forecast period.
  • Based on Application, market is studied across Contraception, Dysfunctional Uterine Bleeding, Endometrial Cancer, Hyperplastic Precursor Lesions, and Regulation of the Menstrual Cycle. The Regulation of the Menstrual Cycle is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Progestrone Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Progestrone Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Progestrone Market, highlighting leading vendors and their innovative profiles. These include Alkem Laboratories Ltd., Aquatic Remedies Pvt. Ltd, Bionpharma, Inc., Blubell Pharma Group Company, Cadila Pharmaceuticals, Caesar & Loretz Gmbh, Cipla Limited, Estrellas Life Sciences Private Limited, Fagron Industry, Glenmark Pharmaceuticals, Intas Pharmaceuticals Ltd., Lupin Limited, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Shandong Octagon Chemicals Limited, Shanghai Yijing Industrial Co., Ltd., Sigmak Life Sciences, Sofgen Pharmaceuticals Llc, Teva Pharmaceuticals Industries Ltd., Virtus Pharmaceuticals Llc, and Wuhan Honor Bio-Pharm Co., Ltd..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Progestrone Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Progestrone Market?
  3. What is the competitive strategic window for identifying opportunities in the Progestrone Market?
  4. What are the latest technology trends and regulatory frameworks in the Progestrone Market?
  5. What is the market share of the leading vendors in the Progestrone Market?
  6. Which modes and strategic moves are suitable for entering the Progestrone Market?


Note: PDF & Excel + Online Access - 1 Year

Table of Contents

194 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Progestrone Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of amenorrhea, breast cancer, and AIDS
5.1.1.2. Growing female infertility rates all over the globe
5.1.1.3. Increasing demand owing to different gynecological treatment
5.1.2. Restraints
5.1.2.1. Concern associated with side effects of progesterone and progestin
5.1.3. Opportunities
5.1.3.1. Technological advancements in the medical field
5.1.3.2. Ongoing research and development activities
5.1.4. Challenges
5.1.4.1. Lack of awareness about hormone therapy
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Progestrone Market, by Type
6.1. Introduction
6.2. Natural Progesterone
6.3. Synthetic Progesterone
7. Progestrone Market, by Mode of Delivery
7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Suspended Form
8. Progestrone Market, by Application
8.1. Introduction
8.2. Contraception
8.3. Dysfunctional Uterine Bleeding
8.4. Endometrial Cancer
8.5. Hyperplastic Precursor Lesions
8.6. Regulation of the Menstrual Cycle
9. Americas Progestrone Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Progestrone Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Progestrone Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Alkem Laboratories Ltd.
13.1.2. Aquatic Remedies Pvt. Ltd
13.1.3. Bionpharma, Inc.
13.1.4. Blubell Pharma Group Company
13.1.5. Cadila Pharmaceuticals
13.1.6. Caesar & Loretz Gmbh
13.1.7. Cipla Limited
13.1.8. Estrellas Life Sciences Private Limited
13.1.9. Fagron Industry
13.1.10. Glenmark Pharmaceuticals
13.1.11. Intas Pharmaceuticals Ltd.
13.1.12. Lupin Limited
13.1.13. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
13.1.14. Shandong Octagon Chemicals Limited
13.1.15. Shanghai Yijing Industrial Co., Ltd.
13.1.16. Sigmak Life Sciences
13.1.17. Sofgen Pharmaceuticals Llc
13.1.18. Teva Pharmaceuticals Industries Ltd.
13.1.19. Virtus Pharmaceuticals Llc
13.1.20. Wuhan Honor Bio-Pharm Co., Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us